Tareq Al Baghdadi, Michael Rothe, Elizabeth Garrett-Mayer, Funda Meric-Bernstam, Kathryn Finch Mileham, Roozbeh Mohajer, Chukwuemeka Ikpeazu, Mehmet Akce, Andrew Gregory, Laura LaNiel Tenner, Raymond Couric Wadlow, Olatunji B. Alese, Stephanie Ann Dublis, David Michael Gill, Jared David Acoba, Abigail Gregory, Dominique C. Hinshaw, Gina N. Grantham, Susan Halabi, Richard L. Schilsky. "Tucatinib + subcutaneous (SC) trastuzumab (Tuc + Trast SC) in patients (pts) with solid tumors with
                    <i>ERBB2</i>
                    alterations (alts): Results from the targeted agent and profiling utilization registry (TAPUR) study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.3104